{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:06:30Z","timestamp":1764331590022,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.ijcard.2005.02.011","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T07:34:19Z","timestamp":1111476859000},"page":"333-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina"],"prefix":"10.1016","volume":"106","author":[{"given":"Dimitris","family":"Tousoulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erini","family":"Bosinakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kotsopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalambos","family":"Antoniades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Katsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christodoulos","family":"Stefanadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2005.02.011_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00001721-200310000-00001","article-title":"Acute coronary syndromes: Virchow's triad revisited","volume":"14","author":"Lee","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ijcard.2005.02.011_bib2","first-page":"160","article-title":"Endothelial function and hemostasis","volume":"89","author":"Becker","year":"2000","journal-title":"Z Kardiol"},{"key":"10.1016\/j.ijcard.2005.02.011_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0008-6363(98)00130-8","article-title":"Procoagulant and proinflammatory activity in acute coronary syndromes","volume":"40","author":"Manten","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2005.02.011_bib4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.02.011_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.02.011_bib6","first-page":"366","article-title":"A review of clinical trials comparing HMG\u2013CoA reductase inhibitors","volume":"16","author":"Illingworth","year":"1994","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijcard.2005.02.011_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-8703(00)90033-4","article-title":"Statins: effective antiatherosclerotic therapy","volume":"139","author":"Blumenthal","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2005.02.011_bib8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0011-393X(97)80105-1","article-title":"Increased thrombin generation and complement activation in patients with type II hyperlipoproteinemia: effects of simvastatin treatment","volume":"58","author":"Di Garbo","year":"1997","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.ijcard.2005.02.011_bib9","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the REFICE (reduction of cholesterol in ischemia and function of endothelium) trial","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.02.011_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(95)91322-X","article-title":"Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication","volume":"346","author":"Stroes","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.02.011_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.02.011_bib12","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/0024-3205(94)00328-9","article-title":"Relationships between serum lipids serotonin platelet aggregation and some fibrinolytic parameters in humans","volume":"55","author":"Malyszko","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.ijcard.2005.02.011_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.bmb.a072928","article-title":"Lipids\u2013thrombosis interface","volume":"50","author":"Mitropoulos","year":"1994","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ijcard.2005.02.011_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin","volume":"353","author":"Rosnenson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.02.011_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(00)00870-0","article-title":"Pravastatin down-regulates inflammatory mediators in human monocytes in vitro","volume":"410","author":"Grip","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijcard.2005.02.011_bib16","first-page":"183","article-title":"Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide","volume":"48","author":"Romano","year":"2000","journal-title":"J Invest Med"},{"key":"10.1016\/j.ijcard.2005.02.011_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","article-title":"Unstable angina\u2014a classification","volume":"80","author":"Braunwald","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.02.011_bib18","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(00)00889-5","volume":"36","author":"Braunwald","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.02.011_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","article-title":"Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study","volume":"ii","author":"Meade","year":"1986","journal-title":"Lancet"},{"issue":"supp 1","key":"10.1016\/j.ijcard.2005.02.011_bib20","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.5551\/jat1994.2.Supplement1_S36","article-title":"Hyperlipidemia and hemostatic system","author":"Morishita","year":"1995","journal-title":"J Atheroscler Thromb"},{"issue":"supp","key":"10.1016\/j.ijcard.2005.02.011_bib21","doi-asserted-by":"crossref","first-page":"9B","DOI":"10.1016\/S0002-9149(02)03268-X","article-title":"Effects of statins on inflammation in patients with acute and chronic coronary syndromes","volume":"91","author":"Kinlay","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2005.02.011_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2796.2000.00715.x","article-title":"Markers of hypercoagulation and von Willebrand factor in postmenopausal women with unstable coronary artery disease. Discriminatory ability regarding unstable coronary artery disease and coronary atherosclerosis using receiver operating characteristics","volume":"248","author":"Nielsen","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijcard.2005.02.011_bib23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/01.ATV.20.2.556","article-title":"HMG\u2013CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells","volume":"20","author":"Bourcier","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2005.02.011_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0735-1097(98)00514-2","article-title":"Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions","volume":"33","author":"Kaesemeyer","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.02.011_bib25","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.02.011_bib26","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2165\/00003495-200363170-00005","article-title":"Effects of HMG\u2013CoA reductase inhibitors on coagulation and fibrinolysis processes","volume":"63","author":"Krysiak","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2005.02.011_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijcard.2003.08.003","article-title":"Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects","volume":"95","author":"Bruni","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2005.02.011_bib28","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.02.011_bib29","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol level","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.02.011_bib30","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2005.02.011_bib31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Pravastatin or atorvastatin evaluation and infection therapy\u2014thrombolysis in myocardial infarction 22 investigators. Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.02.011_bib32","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.0000031568.40630.1C","article-title":"Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction. A myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) substudy","volume":"106","author":"Waters","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.02.011_bib33","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0735-1097(99)00018-2","article-title":"Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile","volume":"33","author":"Dangas","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.02.011_bib34","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0735-1097(99)00023-6","article-title":"Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia","volume":"33","author":"Szczeklik","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.02.011_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0021-9150(00)00397-X","article-title":"Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins","volume":"153","author":"Rauch","year":"2000","journal-title":"Atherosclerosis"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527305004316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527305004316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:17:05Z","timestamp":1759090625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527305004316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0167527305004316"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2005.02.011","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2005.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}